Delivery Order SPE2DX22D0069-SPE2D826F01C2

AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $66,372.00 by the Defense Logistics Agency's Medical Supply Chain on October 13, 2025, with an ultimate completion date of October 14, 2025. This firm fixed-price contract represents a child order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award was competitively procured with no set-aside designation, reflecting the company's established capability to fulfill federal pharmaceutical and medical supply requirements through open competition.

This delivery order falls within AmerisourceBergen Drug Corp's comprehensive pharmaceutical supply portfolio, which includes brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities supporting military and veteran healthcare systems. The contract is executed under the Pharmaceutical Prime Vendor Global Program vehicle, which enables flexible fulfillment of medical procurement needs across the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. As a major pharmaceutical distributor and established federal vendor, AmerisourceBergen Drug Corp continues to serve as a critical supplier for the Department of Defense's medical logistics operations.